UBS(Lux)E.F.-Biotech(USD)P a.SEK/ LU1991432631 /
| NAV6/8/2023 | Chg.-2.4400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 943.1800SEK | -0.26% | reinvestment | Equity Worldwide | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | -2.50 | 0.65 | -0.87 | -3.03 | 12.11 | -0.97 | 5.56 | -5.13 | -4.80 | 1.18 | 2.38 | +0.74% |
| 2022 | -8.92 | -1.62 | 2.79 | -5.31 | -4.00 | 10.88 | 0.91 | 9.71 | 3.35 | 4.98 | 3.19 | -8.29 | +5.52% |
| 2023 | 1.81 | -6.40 | 0.23 | -0.46 | 3.19 | 2.17 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.22% | 20.29% | 25.23% | -% | -% |
| Sharpe ratio | -0.14 | -0.51 | 0.77 | - | - |
| Best month | +3.19% | +3.19% | +10.88% | +12.11% | - |
| Worst month | -8.29% | -8.29% | -8.29% | -8.92% | - |
| Maximum loss | -10.96% | -12.26% | -16.45% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in SEK
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(Lux)E.F.-Biotech(USD)QL a.US... | reinvestment | 97.2100 | +12.58% | - | |
| UBS(Lux)E.F.-Biotech(USD)Q a.USD | reinvestment | 298.8400 | +12.80% | -3.42% | |
| UBS(Lux)E.F.-Biotech(USD)P a.SEK | reinvestment | 943.1800 | +22.90% | - | |
| UBS(Lux)E.F.-Biotech(USD)P a.USD | reinvestment | 681.0500 | +11.65% | -6.33% |
Performance
| YTD | +0.24% | ||
|---|---|---|---|
| 6 Months | -3.47% | ||
| 1 Year | +22.90% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +6.56% | ||
| Year | |||
| 2022 | +5.52% | ||
| 2021 | +0.74% | ||